Phenylacetic Acid

Phenylacetic Acid

SCHEMBL9106985

Cc1ccc(O)cc1C.O=C(O)Cc1ccccc1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.59
CA2 P00918 1/20 0.55
CAMK2A Q9UQM7 1/20 0.55
LMNA P02545 2/20 0.54
FNTA P49354 1/20 0.50
FNTB P49356 1/20 0.50
FFAR1 O14842 1/20 0.48
ABCC4 O15439 1/20 0.47
GAA P10253 1/20 0.47
TSHR P16473 1/20 0.47
PTGS1 P23219 1/20 0.47
HTT P42858 1/20 0.47
SLC22A12 Q96S37 1/20 0.46
PSMB8 P28062 2/20 0.45
PSMB5 P28074 2/20 0.45
ESR2 Q92731 1/20 0.44
CES2 O00748 2/20 0.44
CES1 P23141 2/20 0.44
GPR183 P32249 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylacetic Acid SCHEMBL28136536 0.83 AKR1B1 (0.77) AKR1B1CA2CAMK2ALMNAFFAR1
Phenylacetic Acid SCHEMBL8319811 0.80 CA2 (0.67) AKR1B1CA2CAMK2ALMNAFNTA
Phenylacetic Acid SCHEMBL8862354 0.80 AKR1B1 (0.71) AKR1B1CA2CAMK2ALMNAFNTA
Phenylacetic Acid SCHEMBL29388435 0.79 CA2 (0.86) AKR1B1CA2CAMK2ALMNAFNTA
SCHEMBL11517499 0.78 LMNA (0.60) LMNAFNTAFNTBGAAHTT
SCHEMBL969589 0.77 HPGD (0.55) AKR1B1CA2CAMK2ALMNAABCC4
Phenol SCHEMBL7527608 0.77 ESR2 (0.57) CA2LMNAGAAHTTESR2
Acetic Acid SCHEMBL9106978 0.77 HTT (0.55) CA2LMNAGAAHTTESR2
Phenylacetic Acid SCHEMBL28226480 0.77 AKR1B1 (0.81) AKR1B1CA2CAMK2ALMNAFNTA
SCHEMBL4943262 0.77 HSD17B1 (0.59) AKR1B1CA2CAMK2ALMNAFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140057952-A1 NOVEL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS ALLERGAN, INC. (US) 2014-02-27 US disclosed
US-8618139-B2 Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators ALLERGAN, INC. (US) 2013-12-31 US disclosed
US-20120142739-A1 NOVEL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS ALLERGAN, INC. (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140057952-A1 NOVEL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS S1PR3, S1PR1, S1PR2 AKR1B1 956/4885CA2 3682/4885CAMK2A 901/4885
US-20120142739-A1 NOVEL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS S1PR3, S1PR1, S1PR2 AKR1B1 956/4885CA2 3682/4885CAMK2A 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.